MDDI Online

MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Medtech in a Minute: A Huge Merger Flop, a TAVR Breakthrough, and More

Pressed for time? Here's the medtech news you need most, in one minute or less.

7 Big Healthcare Innovations Coming Out of CES

A look at some of the technologies that blew MD+DI editors away at the Consumer Electronics Show.

A Creative Way to Encourage Resource Recovery

Unused sterile packaging is repurposed into art to support children's health and wellness initiatives.

Zap Surgical Raises $81M for RadioSurgical Robot

The San Carlos, CA-based company has raised a total of $160 million since it was founded in 2014.

Supplier Stories for the Week of January 5

Here’s what was new in the world of medical device suppliers during the week of January 5

A 'Discommon' Approach to Medical Device Accessorizing

Butterfly Network expanded global access to imaging with its affordable handheld Butterfly IQ ultrasound device marketed for under $2000. Can a new family of accessories further ease and expand use?

Does JenaValve’s New Designation Signal the Start of Another Strong Year for TAVR?

2019 was a busy year for the transcatheter aortic valve replacement market. JenaValve’s Breakthrough Device Designation from FDA builds on that momentum and could help make 2020 a stellar year for TAVR.

Allurion Kicks It up a Notch with New Funding and Personnel

The Obesity treatment company has raised $34 million to help it in its bid to get the Elipse Balloon for weight loss approved. Allurion is also seeking to use the funding to expand its presence outside the U.S.

Design Controls, Deconstructed

Here’s what you need to know about design controls and the critical role they play in your regulatory journey.

Abbott's New Designation Helps Advance its Position in LVAD Market

The Abbott Park, IL-based company has won a nod from FDA for a less invasive surgical approach for the HeartMate 3 Left Ventricular Assist Device. The firm’s rival, Dublin-based Medtronic won the same designation for the HVAD in 2018.

AtriCure Completes Patient Enrollment for aMAZE Trial

The Mason, OH-based company inherited Lariat, the device being evaluated in the aMAZE clinical trial, when it acquired SentreHeart for $300 million last year.

Guided Therapeutics Begins 2020 with Renewed FDA Approval Bid

The Norcross, GA-based company is developing the LuViva Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care.

Using Imaging for Early Intervention After a Heart Attack

A new study shows that a radiotracer can effectively image fibroblast activation after a heart attack. This could lead to improved outcomes for heart attack patients.